This review provides a detail of the current literature on the association of estrogen and estrogen receptors in CRC carcinogenesis and potentiates some compounds to be used to enhance the anti‐tumourigenic activity of ERs. The gene discussed is ESR1; the disease is colorectal carcinoma.